Prosight Management, LP Alnylam Pharmaceuticals, Inc. Transaction History

Prosight Management, LP

  • $372 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$120.42 - $169.29 $2.73 Million - $3.84 Million
-22,704 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$127.18 - $173.91 $1.17 Million - $1.6 Million
-9,203 Reduced 28.84%
22,704 $3.71 Million
Q4 2021

Feb 14, 2022
BUY
$159.56 - $209.29 $5.09 Million - $6.68 Million
31,907 New
31,907 $5.41 Million

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email